Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis

Autor: Pageaux, G. (Georges-Philippe), Nzinga, C. (Clovis Lusivika), Ganne, N. (Nathalie), Samuel, D. (Didier), Dorival, C. (Céline), Zoulim, F. (Fabien), Cagnot, C. (Carole), Decaens, T. (Thomas), Thabut, D. (Dominique), Asselah, T. (Tarik), Mathurin, P. (Philippe), Habersetzer, F. (Francois), Bronowicki, J. (Jean-Pierre), Guyader, D. (Dominique), Rosa, I. (Isabelle), Leroy, V. (Vincent), Chazouilleres, O. (Olivier), de Ledinghen, V. (Victor), Bourliere, M. (Marc), Causse, X. (Xavier), Cales, P. (Paul), Metivier, S. (Sophie), Loustaud-Ratti, V. (Véronique), Riachi, G. (Ghassan), Alric, L. (Laurent), Gelu-Simeon, M. (Moana), Minello, A. (Anne), Gournay, J. (Jérôme), Geist, C. (Claire), Tran, A. (Albert), Abergel, A. (Armand), Portal, I. (Isabelle), d'Alteroche, L. (Louis), Raffi, F. (François), Fontaine, H. (Hélène), Carrat, F. (Fabrice), Pol, S. (Stanislas), Baumert, Thomas F., Doffoel, M. (Michel), Mutter, C. (Catherine), Simo-Noumbissie, P. (Pauline), Razi, E. (Esma)

Publikováno v: BMC Infectious Diseases
BMC Infectious Diseases, BioMed Central, 2022, 22 (1), pp.94. ⟨10.1186/s12879-022-07076-0⟩
BMC Infectious Diseases, 2022, 22 (1), pp.94. ⟨10.1186/s12879-022-07076-0⟩
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-12 (2022)

Background In HCV-infected patients with advanced liver disease, the direct antiviral agents-associated clinical benefits remain debated. We compared the clinical outcome of patients with a previous history of decompensated cirrhosis following treatm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a64389812730cdee1f356f6f46786008
https://hal.archives-ouvertes.fr/hal-03555553/document

BRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease

Autor: Oussalah, A. (Abderrahim), Avogbe, P. (Patrice Hodonou), Guyot, E. (Erwan), Chery, C. (Céline), Guéant-Rodriguez, R. (Rosa-Maria), Ganne-Carrié, N. (Nathalie), Cobat, A. (Aurélie), Moradpour, D. (Darius), Nalpas, B. (Bertrand), Negro, F. (Francesco), Poynard, T. (Thierry), Pol, S. (Stanislas), Bochud, P. (Pierre-Yves), Abel, L. (Laurent), Jeulin, H. (Hélène), Schvoerer, E. (Evelyne), Chabi, N. (Nicodème), Amouzou, E. (Emile), Sanni, A. (Ambaliou), Barraud, H. (Hélène), Rouyer, P. (Pierre), Josse, T. (Thomas), Goffinet, L. (Laetitia), Jouve, J. (Jean-Louis), Minello, A. (Anne), Bonithon-Kopp, C. (Claire), Thiefin, G. (Gérard), Di Martino, V. (Vincent), Doffoel, M. (Michel), Richou, C. (Carine), Raab, J. (Jean-Jacques), Hillon, P. (Patrick), Bronowicki, J. (Jean-Pierre), Guéant, J. (Jean-Louis), CiRCE Study Group

The molecular mechanisms of hepatocellular carcinoma (HCC) carcinogenesis are still not fully understood. DNA repair defects may influence HCC risk. The aim of the study was to look for potential genetic variants of DNA repair genes associated with H

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______4060::543d4740789905e5c7a34a200648c7ac